| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000258904.1 |
GSK1904529A |
Bladder urothelial carcinoma |
0.017618776 |
Resistant |
| ENSG00000258904.1 |
GSK1904529A |
Esophageal cancer |
0.011576235 |
Resistant |
| ENSG00000258904.1 |
GSK1904529A |
Colon adenocarcinoma |
0.028549041 |
Sensitive |
